Wells Fargo & Company »

Iterum Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Iterum Therapeutics (ITRM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Iterum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iterum Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iterum Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $92 85 1.09
2024-06-30 $1.5k 1.3k 1.15
2024-03-31 $2.0k 1.3k 1.54
2023-12-31 $2.5k 1.3k 1.97
2023-09-30 $1.0k 1.3k 0.80
2023-06-30 $91 85 1.07
2022-12-31 $71 85 0.84
2022-09-30 $0 305 0.00